highli
pathogen
influenza
hpai
viru
first
emerg
caus
sever
human
diseas
hong
kong
sinc
becom
entrench
poultri
across
asia
africa
zoonot
transmiss
human
sometim
fatal
outcom
contrast
human
season
influenza
diseas
higher
report
casefat
rate
rang
hong
kong
recent
reason
unusu
sever
human
diseas
remain
unclear
within
lung
alveolar
epithelium
primari
target
cell
influenza
viru
although
novel
influenza
viru
swine
origin
recent
emerg
caus
pandem
pathogenesi
viru
remain
import
public
health
issu
viru
remain
pandem
public
health
threat
either
directli
reassort
novel
pandem
viru
epitheli
cell
line
major
caviti
bodi
function
select
secret
adsorpt
provid
barrier
extern
environ
human
lung
alveolar
epithelium
consist
continu
layer
tissu
made
two
princip
cell
type
flatten
type
alveolar
epitheli
cell
cubodi
type
ii
alveolar
epitheli
cell
type
alveolar
epitheli
cell
cover
alveolar
surfac
function
broad
thin
layer
gaseou
exchang
cell
highli
polar
sinc
plasma
membran
cell
divid
two
discret
domain
name
apic
domain
face
lumin
air
surfac
basolater
domain
face
system
circul
larg
thin
surfac
make
extrem
suscept
injuri
inhal
pathogen
data
viru
infect
cytokin
respons
alveolar
epitheli
cell
inform
effect
cell
polar
viru
replic
virusinduc
host
respons
though
influenza
viru
infect
local
primarili
respiratori
system
hpai
avian
speci
associ
system
dissemin
viru
multipl
organ
increas
evid
influenza
virus
found
peripher
blood
gastrointestin
tract
occasion
even
central
nervou
system
human
dissemin
may
contribut
unusu
diseas
manifest
includ
multipl
organ
dysfunct
close
anatom
relationship
alveolar
epithelium
lung
microvascular
endothelium
togeth
distribut
put
influenza
viru
receptor
endotheli
cell
surfac
make
import
parallel
investig
lung
epithelium
lung
endothelium
carri
present
studi
investig
infect
polar
primari
human
type
ilik
alveolar
epitheli
cell
lung
microvascular
endotheli
cell
influenza
viru
low
pathogen
human
season
influenza
viru
hpai
viru
studi
found
influenza
virus
effici
infect
alveolar
epitheli
cell
apic
basolater
surfac
epithelium
irrespect
rout
infect
virus
preferenti
releas
apic
surfac
alveolar
epithelium
wherea
lung
microvascular
endotheli
cell
influenza
viru
fail
replic
convincingli
contrast
influenza
viru
show
evid
replic
follow
infect
either
apic
basolater
rout
new
viru
releas
side
cell
previous
report
influenza
viru
potent
induc
cytokin
chemokin
eg
rant
comparison
viru
alveolar
epitheli
cell
influenza
viru
induc
chemokin
secret
apic
basolater
aspect
polar
alveolar
epithelium
human
influenza
viru
led
predominantli
apic
secret
find
enhanc
understand
viru
infect
may
spread
within
beyond
lung
influenza
viru
infect
innat
host
respons
may
contribut
modul
aggrav
tissu
patholog
primari
alveolar
epitheli
cell
isol
human
nontumor
lung
tissu
obtain
patient
undergo
lung
resect
depart
cardiothorac
surgeri
queen
mari
hospit
queen
elizabeth
hospit
hong
kong
sar
studi
approv
hong
kong
univers
hospit
author
hong
kong
west
kowloon
centraleast
respect
institut
review
board
use
modif
method
previous
describ
briefli
lung
tissu
minc
piec
mm
thick
use
tissu
chopper
tissu
digest
use
combin
trypsin
elastas
min
shake
waterbath
cell
popul
purifi
combin
differenti
cell
attach
percol
densiti
gradient
centrifug
magnet
cell
sort
cell
maintain
humidifi
atmospher
liquidcov
condit
growth
medium
chang
daili
start
h
plate
cell
purifi
cell
pellet
passag
resuspend
medium
final
concentr
allow
seed
onto
collagen
coat
transwel
support
corn
cultur
day
small
airway
cultur
medium
sagm
lonza
apic
basolater
chamber
transwel
cell
spread
form
confluent
monolay
cultur
medium
chang
everi
h
concomit
increas
transepitheli
electr
resist
ter
measur
use
epitheli
tissu
voltohmmet
evom
ter
calcul
measur
electr
resist
ohm
multipli
surfac
area
filter
method
alreadi
establish
laboratori
use
modif
method
previous
describ
transepitheli
electri
resist
teer
reach
ohm
demonstr
paracellular
restrict
alveolar
cell
prepar
compet
format
tight
junction
complex
within
polar
alveolar
epitheli
cell
model
assess
cell
use
viru
infect
experi
primari
human
lung
microvascular
endotheli
cell
hlmve
purchas
lonza
walkersvil
inc
us
maintain
medium
growth
supplement
suppli
manufactur
contain
fetal
bovin
serum
fb
hydrocortison
human
endotheli
growth
factor
vascular
endotheli
cell
growth
factor
human
fibroblast
growth
factor
basic
long
insulinlik
growth
ascorb
acid
antibiot
medium
chang
everi
h
confluenc
hlmve
seed
apic
compart
pore
size
transwel
support
corn
cell
densiti
cell
cultur
day
medium
chang
apic
basolater
compart
everi
h
transepitheli
electri
resist
teer
reach
ohm
cell
use
viru
infect
experi
use
hpai
viru
ahong
viru
isol
patient
fatal
influenza
diseas
hong
kong
ahong
repres
season
influenza
viru
compar
studi
virus
initi
isol
subsequ
maintain
madindarbi
canin
kidney
mdck
cell
clone
limit
dilut
seed
viru
stock
prepar
mdck
cell
viru
infect
assess
titrat
tissu
cultur
infect
dose
mdck
cell
influenza
viru
use
studi
handl
biosafeti
level
facil
depart
microbiolog
univers
hong
kong
viru
inocul
procedur
design
determin
role
cell
polar
direct
infect
viru
releas
cytokin
secret
polar
type
ilik
alveolar
epitheli
cell
hlmve
seed
apic
surfac
transwel
membran
infect
apic
basolater
surfac
respect
apic
infect
viru
ad
apic
compart
transwel
figur
basolater
infect
viru
ad
onto
transwel
membran
transwel
orient
upsid
figur
orient
transwel
apic
infect
situat
resum
h
viru
inocul
wash
step
seri
experi
use
moi
evalu
differ
two
rout
infect
term
releas
newli
form
viru
moi
determin
percentag
cell
infect
cytokin
releas
evid
viral
infect
establish
assay
viral
matrix
rna
h
post
infect
quantit
rtpcr
b
viral
antigen
express
immunofluoresc
stain
mous
antiinfluenza
nucleoprotein
matrix
antibodi
conjug
fitc
dako
imagen
dako
diagnost
ltd
eli
uk
c
assay
infecti
viru
cell
cultur
supernat
assay
demonstr
complet
viru
replic
dnasetr
mrna
infect
cell
model
extract
h
post
infect
use
rneasi
mini
kit
qiagen
hilden
germani
cdna
synthes
mrna
oligodt
primer
superscript
iii
revers
transcriptas
invitrogen
quantifi
realtim
quantit
pcr
analysi
lightcycl
roch
mannheim
germani
gene
express
profil
cytokin
interferon
beta
chemokin
rant
viral
matrix
gene
quantifi
normal
use
housekeep
gene
product
mrna
concentr
rant
protein
influenza
viru
infect
type
ilik
alveolar
epitheli
cell
measur
specif
elisa
assay
r
system
minneapoli
mn
usa
sampl
cultur
supernat
irradi
ultraviolet
light
ultra
violet
cross
linker
min
inactiv
infecti
viru
elisa
assay
done
previou
experi
confirm
dose
ultraviolet
light
use
affect
cytokin
concentr
measur
elisa
data
shown
type
ilik
alveolar
epitheli
cell
cultur
transwel
insert
hlmve
cell
pellet
fix
formalin
section
follow
lectin
histochemistri
publish
previous
cell
microwav
mm
citrat
buffer
ph
min
block
tb
min
avidinbiotin
block
kit
vector
incub
hrp
conjug
sambucu
nigra
agglutinin
sna
ey
laboratori
biotinyl
mali
malii
vector
digoxigenin
conjug
maa
roch
h
room
temperatur
rt
block
bovin
serum
albumin
min
rt
incub
strepabc
complex
dako
cytom
dilut
min
rt
develop
perform
use
aec
substrat
kit
vector
rt
min
nuclei
counterstain
mayer
hematoxylin
section
dri
mount
dako
aqueou
mount
dako
cytom
duck
intestin
section
use
control
without
pretreat
sialic
acid
sia
specif
neuraminidas
glyko
ensur
sia
specif
target
twotail
student
ttest
use
compar
differ
viral
titer
influenza
viru
infect
cell
supernat
earli
late
time
point
quantit
cytokin
chemokin
mrna
protein
express
profil
mock
influenza
viru
infect
cell
compar
use
oneway
anova
follow
bonferroni
multiplecomparison
test
differ
consid
signific
p
lectin
histochemistri
primari
cultur
human
type
ilik
alveolar
epitheli
cell
use
sna
maa
show
malii
recogn
accept
avian
influenza
receptor
bound
strongli
type
ilik
alveolar
epitheli
cell
figur
stain
sna
recogn
human
influenza
receptor
type
ilik
alveolar
epitheli
cell
promin
type
ilik
alveolar
epitheli
cell
result
similar
report
shinya
et
al
lectin
histochemistri
hlmve
cell
show
bind
sna
figur
malii
figur
agre
previou
report
influenza
virus
abl
infect
type
ilik
alveolar
epitheli
cell
apic
basolater
compart
influenza
matrix
gene
express
increas
h
h
post
infect
p
apic
infect
result
greater
matrix
gene
copi
number
h
post
infect
compar
basolater
infect
type
ilik
alveolar
epitheli
cell
differ
less
mark
h
h
post
infect
matrix
gene
copi
number
type
ilik
alveolar
epitheli
cell
infect
influenza
viru
apic
higher
cell
infect
via
basolater
aspect
three
time
point
h
h
h
post
infect
figur
viral
protein
express
detect
immunofluores
influenza
viru
infect
alveolar
epitheli
cell
infect
apic
basolater
aspect
number
cell
infect
significantli
higher
p
p
influenza
viru
respect
viru
inocul
apic
basolater
side
figur
assay
perform
supernat
collect
infect
type
ilik
alveolar
epitheli
cell
infect
highli
pathogen
influenza
low
pathogen
human
influenza
virus
determin
infecti
viru
yield
regardless
infect
rout
viru
strain
increas
titer
observ
supernat
collect
apic
compart
basolater
compart
figur
legend
ab
bb
figur
releas
newli
form
viru
type
ilik
alveolar
epitheli
cell
infect
via
apic
basolater
surfac
either
influenza
virus
restrict
apic
side
cell
figur
follow
basolater
infect
titer
viru
shed
apic
aspect
cell
higher
p
follow
influenza
viru
infect
rather
influenza
viru
infect
figur
order
better
understand
implic
effect
cell
polar
viru
infect
relat
viru
dissemin
via
system
circul
investig
replic
influenza
virus
polar
hlmve
cell
convinc
evid
influenza
viru
replic
hlmve
cell
infect
via
either
apic
basolater
aspect
figur
interestingli
hlmve
cell
infect
influenza
viru
via
either
apic
basolater
aspect
result
viru
releas
apic
basolater
aspect
cell
p
figur
next
investig
effect
cell
polar
cytokin
chemokin
induct
influenza
viru
infect
primari
human
type
ilik
alveolar
epitheli
cell
specif
want
determin
whether
apic
basolater
infect
rout
led
qualit
quantit
differ
profil
cytokin
induc
effici
infect
cell
apic
rout
basolater
rout
previous
report
us
trend
influenza
viru
infect
led
increas
level
cytokin
mrna
h
post
infect
compar
influenza
viru
irrespect
whether
infect
occur
apic
black
bar
basolater
grey
bar
aspect
figur
differ
influenza
virus
achiev
statist
signific
ifn
follow
apic
p
basolater
p
infect
figur
follow
apic
infect
p
figur
follow
basolater
infect
p
figur
trend
suggest
chemokin
gene
rant
hyperinduc
influenza
viru
compar
influenza
viru
statist
signific
achiev
p
apic
infect
p
basolater
infect
figur
similar
cytokin
chemokin
express
profil
observ
h
h
post
infect
influenza
viru
infect
type
ilik
alveolar
epitheli
cell
data
shown
inactiv
viru
ultraviolet
irradi
prior
infect
type
ilik
alveolar
epitheli
cell
abolish
cytokin
induct
data
shown
suggest
viru
replic
requir
cytokin
induct
furthermor
even
increas
moi
influenza
viru
result
cytokin
mrna
express
level
level
similar
induc
influenza
viru
data
shown
broadli
data
apic
infect
consist
previou
find
differenti
induct
proinflammatori
cytokin
influenza
viru
alveolar
epitheli
cell
thu
confirm
differ
also
appli
polar
alveolar
epithelium
follow
infect
via
basolater
aspect
next
investig
whether
polar
secret
cytokin
protein
type
ilik
alveolar
epitheli
cell
infect
influenza
virus
concentr
rant
ifn
measur
elisa
apic
basolater
cultur
supernat
type
ilik
alveolar
epitheli
cell
infect
apic
rout
parallel
gene
express
profil
influenza
viru
elicit
chemokin
releas
type
ilik
alveolar
epitheli
cell
influenza
viru
h
post
infect
influenza
viru
induc
protein
secret
found
apic
side
polar
type
ilik
alveolar
epitheli
cell
level
significantli
higher
mock
infect
cell
p
influenza
viru
infect
cell
p
addit
significantli
secret
basolater
side
influenza
viru
infect
alveolar
epitheli
cell
compar
mock
influenza
viru
infect
cell
p
contrast
rant
appear
secret
apic
aspect
influenza
viru
infect
type
ilik
alveolar
epitheli
cell
although
result
achiev
statist
signific
figur
fail
detect
ifn
protein
supernat
type
ilik
alveolar
epitheli
cell
influenza
viru
infect
data
shown
note
limit
detect
ifn
elisa
high
pgml
lack
sensit
assay
like
respons
lack
detect
studi
compar
human
influenza
viru
highli
pathogen
influenza
viru
investig
whether
differ
polar
viru
infect
host
cytokin
respons
human
polar
type
ilik
alveolar
epithelium
basolater
aspect
alveolar
epithelium
lie
close
proxim
basolater
aspect
lung
microvascular
endotheli
cell
rais
question
whether
viru
regress
basolater
aspect
type
ilik
alveolar
epitheli
cell
infect
lung
microvascular
endotheli
cell
basolater
aspect
altern
sinc
influenza
viru
believ
dissemin
system
detect
peripher
circul
relev
understand
whether
endotheli
cell
infect
via
apic
aspect
therebi
allow
viru
blood
circul
infect
cell
traffic
outward
infect
lung
alveolar
epithelium
basolater
aspect
lung
endothelium
cover
total
surfac
area
alveoli
sac
rest
cover
alveolar
epithelium
tropism
influenza
viru
alveolar
epithelium
endothelium
import
pathogenesi
influenza
viru
infect
human
previous
polar
influenza
viru
infect
releas
studi
low
pathogen
influenza
viru
subtyp
low
pathogen
avian
influenza
viru
subtyp
human
airway
tracheabronchi
epitheli
cell
demonstr
newli
form
influenza
viru
releas
apic
surfac
respiratori
epithelium
howev
mouseadapt
influenza
viru
wsn
strain
sendi
viru
shown
bud
apic
basolater
domain
vesticular
stomat
viru
retrovirus
releas
basolater
domain
polar
cell
symmetr
asymmetr
bind
intern
bud
viru
polar
epitheli
cell
cultur
therefor
would
potenti
implic
viral
pathogenesi
exampl
coronaviru
apic
releas
transmiss
gastroenter
viru
result
local
infect
vivo
basolater
releas
mous
hepat
viru
mhv
epitheli
cell
result
system
infect
mous
studi
mhv
initi
replic
nasal
epithelium
dissemin
throughout
bodi
basolater
releas
mhv
epitheli
cell
anim
circul
postul
first
step
establish
system
infect
show
influenza
virus
preferenti
infect
type
ilik
alveolar
epitheli
cell
apic
surfac
higher
level
viral
gene
express
well
higher
percentag
cell
infect
compar
basolater
infect
figur
expect
sinc
respiratori
virus
need
adapt
effici
infect
cell
via
apic
surfac
surfac
expos
respiratori
lumen
therefor
access
infect
influenza
viru
releas
newli
form
viru
restrict
apic
aspect
irrespect
whether
alveolar
epitheli
cell
infect
apic
basolater
rout
figur
expect
viru
appear
dissemin
beyond
lung
similar
observ
report
parainfluenza
viru
infect
epithelia
viru
preferenti
enter
exit
via
apic
surfac
given
propens
dissemin
beyond
lung
initi
hypothes
influenza
viru
may
releas
apic
basolater
aspect
prove
case
similar
respect
ie
viru
releas
predominantli
via
apic
aspect
irrespect
rout
infect
cell
figur
effici
infect
via
basolater
aspect
lower
apic
aspect
virus
cell
infect
viru
via
basolater
aspect
result
greater
fold
higher
viru
yield
apic
surfac
cell
compar
infect
investig
viru
replic
polar
lung
microvascular
endothelium
anatom
close
proxim
alveolar
epithelium
convinc
evid
replic
viru
polar
hlmve
cell
figur
contrast
viru
could
initi
product
replic
cell
either
aspect
viru
releas
also
occur
apic
basolater
aspect
cell
figur
although
neither
influenza
virus
effici
releas
via
basolater
aspect
alveolar
epithelium
viru
replic
like
lead
weaken
tightjunct
cell
death
thu
provid
virus
access
underli
tissu
basolater
aspect
microvascular
endotheli
cell
lung
microvascular
endothelium
also
compris
total
surfac
area
alveoli
influenza
viru
entri
via
basolater
aspect
hlmve
cell
replic
within
releas
apic
aspect
cell
could
lead
viremia
dissemin
infect
fact
hpai
viru
precursor
form
cleav
proteas
restrict
lung
facilit
dissemin
viru
infect
fact
influenza
viru
infect
hlmve
cell
basolater
aspect
would
facilit
dissemin
viru
via
blood
stream
furthermor
observ
hlmve
cell
infect
via
apic
aspect
releas
viru
basolater
aspect
well
apic
side
suggest
system
circul
viru
initi
infect
lung
parenchyma
via
endotheli
rout
particularli
relev
sinc
recent
studi
mice
shown
hpai
viru
experiment
inject
muscl
led
fatal
viru
infect
viru
establish
infect
lung
brain
furthermor
specul
anecdot
evid
viru
initi
infect
via
ingest
gastrointestin
tract
possibl
viru
system
circul
establish
foothold
lung
therefor
import
observ
infect
type
alveolar
epitheli
cell
undergo
either
cytolyt
apoptot
death
shed
infect
type
alveolar
epitheli
cell
may
inflamm
underlin
interstiti
cell
may
expos
alveolar
lumen
fluid
contain
high
concentr
viru
reconstitut
alveolar
epitheli
surfac
depend
regener
type
alveolar
epitheli
cell
progenitor
type
ii
alveolar
epitheli
cell
howev
intact
basement
membran
essenti
epitheli
cell
prolifer
occur
alveolar
basement
membran
denud
alveolar
epitheli
cell
acceler
epitheli
prolifer
epitheli
layer
becom
confluent
nevertheless
type
ii
alveolar
epitheli
cell
could
domin
epitheli
surfac
prevent
reappear
type
alveolar
epitheli
cell
injuri
signal
type
alveolar
epitheli
cell
persist
microenviron
previou
report
human
lung
epitheli
cell
line
infect
human
influenza
viru
show
low
product
interferon
previous
shown
compar
influenza
viru
influenza
viru
differenti
upregul
cytokin
chemokin
gene
express
alveolar
epitheli
cell
macrophag
vitro
experi
profil
differenti
upregul
cytokin
correspond
elev
mig
level
patient
serum
interestingli
mig
report
play
role
pathogenesi
tissu
necrosi
vascular
damag
associ
certain
ebvposit
lymphoprolif
process
result
may
dictat
differ
pathogenesi
downstream
cytokin
chemokin
respons
event
contribut
unusu
advers
patholog
patient
studi
first
demonstr
polar
secret
cytokin
influenza
infect
alveolar
epithelium
secret
chemokin
notabl
apic
basolater
aspect
found
influenza
viru
infect
type
ilik
alveolar
epitheli
cell
influenza
viru
infect
cell
could
potenti
relev
pathogenesi
influenza
viru
infect
patient
basolater
releas
chemotact
influenza
viru
infect
type
ilik
alveolar
epitheli
cell
recruit
lymphocyt
capillari
circul
alveoli
bind
chemokin
receptor
recruit
leukocyt
specif
lead
rapid
chang
cell
shape
behavior
subpopul
leukocyt
make
capabl
migrat
blood
vascular
endothelium
site
inflamm
previou
studi
transendotheli
migrat
indic
retain
endotheli
cell
could
induc
transendotheli
chemotaxi
activ
cell
anoth
investig
biolog
activ
human
recombin
investig
verifi
chemotact
properti
toward
human
peripher
blood
monocyt
stimul
human
peripher
blood
lymphocyt
neutrophil
one
studi
use
endotheli
cell
adhes
assay
demonstr
effect
potenti
cell
adhes
endothelium
potent
secret
apic
basolater
side
infect
alveolar
type
ilik
alveolar
epitheli
cell
observ
would
suggest
possibl
direct
recruit
henc
migrat
cell
monocyt
lung
blood
capillari
microvascular
transendotheli
migrat
thu
macrophag
differenti
recruit
monocyt
may
domin
alveolar
space
lymphocyt
may
occupi
interstiti
space
previous
document
autopsi
report
patient
die
influenza
viru
infect
cytokin
secret
macrophag
accumul
within
alveoli
augment
cytokin
chemokin
cascad
may
result
sinc
influenza
viru
reportedli
resist
antivir
effect
interferon
lead
delay
apoptosi
infect
macrophag
clearanc
viru
lung
inflamm
would
take
longer
period
time
season
influenza
infect
prolong
inflamm
would
eventu
result
patholog
featur
diffus
alveolar
damag
hemorrhag
final
interstiti
fibrosi
key
observ
patient
studi
demonstr
influenza
virus
effici
infect
alveolar
epitheli
cell
apic
basolater
surfac
epithelium
releas
newli
form
viru
mainli
apic
side
epithelium
contrast
influenza
viru
influenza
viru
effici
infect
polar
lung
microvascular
endotheli
cell
either
apic
basolater
aspect
also
releas
either
aspect
polar
cell
like
relev
pathogenesi
provid
possibl
explan
entri
respiratori
tract
via
blood
stream
propos
suggest
gastrointestin
tract
portal
entri
viru
addit
releas
inflammatori
mediat
may
import
contributor
pathogenesi
diseas
detail
studi
mechan
alveolar
epitheli
cell
damag
regener
mediat
involv
process
import
understand
pathogenesi
human
diseas
author
declar
compet
interest
mcwc
rwyc
jsmp
conceiv
studi
plan
overal
experiment
design
wrote
manuscript
mcwc
rwyc
carri
experi
interpret
result
cli
cch
kmi
carri
experi
laboratori
assist
experi
laboratori
whc
ckl
provid
lung
biopsi
specimen
jmn
develop
method
immunohistochemistri
lectin
stain
yg
critic
review
manuscript
